Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
May 05, 2025 | May 06, 2025 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $21.05 | $37,280 | -1.36% |
Feb 11, 2025 | Feb 13, 2025 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $24.33 | $137,276 | -4.32% |
Feb 03, 2025 | Feb 05, 2025 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $20.12 | $103,940 | -4.04% |
Jan 22, 2025 | Jan 24, 2025 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $18.94 | $30,002 | -1.47% |
Sep 09, 2024 | Sep 10, 2024 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $11.52 | $25,240 | -1.99% |
Feb 01, 2024 | Feb 02, 2024 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $8.53 | $35,789 | -4.05% |
Jan 23, 2024 | Jan 25, 2024 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $9.07 | $14,138 | -1.94% |
Oct 03, 2023 | Oct 04, 2023 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $8.25 | $25,504 | -3.71% |
Feb 01, 2023 | Feb 03, 2023 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $21.75 | $38,697 | -2.12% |
Jan 24, 2023 | Jan 26, 2023 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $21.9 | $33,952 | -2.38% |
Oct 04, 2022 | Oct 07, 2022 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $25.68 | $78,119 | -4.46% |
Jan 31, 2022 | Feb 02, 2022 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $27.4 | $30,825 | -1.64% |
Jan 24, 2022 | Jan 26, 2022 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $24.98 | $46,838 | -3.10% |
Oct 04, 2021 | Oct 05, 2021 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $24.77 | $75,746 | -4.81% |
Aug 17, 2021 | Aug 17, 2021 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $17.12 | $24,086 | -2.17% |
Feb 05, 2021 | Feb 09, 2021 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $31.5 | $70,864 | -3.65% |
Feb 02, 2021 | Feb 04, 2021 | Heerma Peter Chief Commercial Officer | Sell | Travere Therapeutics, Inc. | TVTX | $29.83 | $33,589 | -1.93% |
Oct 02, 2020 | Oct 06, 2020 | Heerma Peter Chief Commercial Officer | Sell | Retrophin, Inc. | RTRX | $19.13 | $83,691 | -9.37% |